Apheresis Machine Kaneka MA-03
by Kaneka Pharma America Corp.
Apheresis Machine Kaneka MA-03 is an apheresis system (FDA unclassified) made by Kaneka Pharma America Corp., listed in FDA GUDID since 25 Sep 2014 (UDI-DI 04987671040374), registry data as of 22 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number04987671040374 | Date25 Sep 2014 | StatusListed |
Official records
- AccessGUDID record 04987671040374
From the FDA record
- Device description
- Indications for FH: The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma. Indications for FSGS: The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Apheresis Machine
- Generic name
- Apheresis system
- Model / reference
- KANEKA MA-03
- Primary DI / UDI-DI
- 04987671040374
- FDA product code
- PBN, MMY
- GMDN term
- Apheresis system
- Device class
- Unclassified
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Apheresis system.